Ovoca Bio Company Description

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health.

It’s lead product is BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder.

The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.

Ovoca Bio plc

Country	Ireland
Founded	1985
Industry	Biotechnology
Sector	Healthcare
Employees	5
CEO	Kirill Golovanov

Contact Details

Address: 17 Pembroke Street Upper Dublin, D02 AT22 Ireland
Phone	353 1 661 9819
Website	ovocabio.com

Stock Details

Ticker Symbol	OVXA
Exchange	Euronext Dublin
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	IE00B4XVDC01
SIC Code	2834

Key Executives

Name	Position
Kirill Andreyevich Golovanov	Interim Chairman of the Board and Chief Executive Officer
Dmitriy Nikitashenko	Vice President of Finance
Reneta Nikolova	Corporate Secretary